Nov 21, 2022
15:1
For every share held, investors received 15. The price per share adjusted from $973.50 to $64.90.
The split itself did not change the total investment value.
Eli Lilly and Company (B3:LILY34) operates in the Pharmaceuticals: major industry.
Eli Lilly and Company company overviewEli Lilly and Company's most recent stock split was on November 21, 2022. It was a 15-for-1 forward split, so shareholders received 15 shares for every share they held.
Eli Lilly and Company has split its stock once. This history records one forward split, on November 21, 2022.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Eli Lilly and Company's 15-for-1 split on November 21, 2022, every share became 15 shares.
Eli Lilly and Company has not announced a new split in our records. Its most recent split was on November 21, 2022, 3 years ago. Companies announce splits in advance, and any new B3:LILY34 split will appear on this page.